Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003)

Drug and Alcohol Dependence

Volumn 82, Issue SUPPL. 1, 2006, Pages

  Peretti Watel, Patrick ^a,b   Spire, Bruno ^b   Lert, France ^b   Obadia, Yolande ^a,b  

^a Regional Centre for Disease Control of South Eastern France   (France)

^b INSERM   (France)

Author keywords

Adherence to treatment; Alcohol abuse; Drug use patterns; HIV AIDS; Multiple addiction

Indexed keywords

AMYL NITRATE; ANTIRETROVIRUS AGENT; CANNABIS; ILLICIT DRUG; NICOTINE;

ADULT; ALCOHOL ABUSE; ARTICLE; CLUSTER ANALYSIS; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG USE; FEMALE; FRANCE; HEALTH SURVEY; HEROIN DEPENDENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT CARE; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE;

ADULT; AMPHETAMINE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLUSTER ANALYSIS; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PATIENT COMPLIANCE; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; TOBACCO USE DISORDER;

CANNABIS;

EID: 33744902864     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(06)80012-8     Document Type: Article

References (41)

1. Arnsten J.H., Demas P.A., and Grant R.W. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J. Gen. Intern. Med. 17 (2002) 377-381
2. Bangsberg D.R., Moss A.R., and Deeks S.G. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J. Antimicrob. Chemother. 53 (2004) 696-699
3. Berg K.M., Demas P.A., Howard A.A., Schoenbaum E.E., Gourevitch M.N., and Arnsten J.H. Gender differences in factors associated with adherence to antiretroviral therapy. J. Gen. Intern. Med. 19 (2004) 1111-1117
4. Bogart L.M., Catz S.L., Kelly J.A., and Benotsch E.G. Factors influencing physicians judgments of adherence and treatment decisions for patients with HIV disease. Med. Decis. Making 21 (2001) 28-36
5. Bouhnik A.D., Chesney M., Carrieri P., Gallats H., Moreau J., and Moatti J.P. Nonadherence among HIV-infected injecting drug users: the impact of social instability. J. Acquir. Immune Defic. Syndr. 31 (2002) 149-153
6. Broers B., Morabia A., and Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch. Intern. Med. 154 (1994) 1121-1127
7. Carrieri P., Raffi F., Lewden C., Sobel A., Michelet C., Cailleton V., Chêne G., Leport C., Moatti J.P., and Spire B. Impact of early versus late adherence to highly active antiretroviral therapy on immunovirological response: a 3-year follow-up study. Antiviral Therapy 8 (2003) 585-594
8. Carrieri P., Spire B., and Duran S. Health-related quality of life after 1 year of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 32 (2003) 38-47
9. Catz S.L., Kelly J.A., Bogart L.M., Benotsch E.G., and MacAuliffe T.L. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 19 (2000) 124-133
10. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., and Zwickl B. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials the AACTG adherence instruments. AIDS Care 12 (2000) 255-266
11. Cook R.L., Sereika S.M., and Hunt S.C. Problem drinking and medication adherence among persons with HIV infection. J. Gen. Intern. Med. 16 (2001) 83-88
12. Duran S., Peytavin G., Carrieri P., Raffi F., Ecobichon J.L., Pereira E., Cassuto G.P., Spire B., and Leport C. The detection of non-adherence by self-administered questionnatres can be optimized by protease inhibitor plasma concentration determination. AIDS 17 (2003) 1096-1099
13. Everitt B. Cluster Analysis (1993), Edward Arnold, London
14. Feroni I., Peretti-Watel P., Masut A., Coudert C., Paraponaris A., and Obadia Y. French general practitioners' prescribing in high-dosage buprenorphine maintenance treatment is existing training (good) enough?. Addict. Behav. 30 (2004) 187-191
15. Ferrando S.J., Wall T.L., Batki S.L., and Sorensen J.L. Psychiatrie morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease. Am. J. Drug Alcohol Abuse 22 (1996) 475-487
16. Golin C.E., Liu H., Hays R.D., Miller L.G., Beck C.K., and Ickovics J. A prospective study of predictors of adherence to combination antiretroviral medication. J. Gen. Intern. Med. 17 (2002) 756-765
17. Gordillo V., del Amo J., Soriano V., and Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13 (1999) 1763-1769
18. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom test for nicotine dep endence: a revision of the Fagerstrom tolerance questionnaire. Br. J. Addict. 86 9 (1991) 1119-1127
19. Hecht F.M., Colfax G., Swanson M., and Chesney M. Adherence and effectiveness of protease inhibitors in clinical practice. Paper presented at the 5th Conference on Retroviruses and Opportunistic Infections. Chicago (1998)
20. Heckman B.D., Catz S.L., Heckman T.G., Miller J.G., and Kalichman S.C. Adherence to antiretroviral therapy in rural persons living with HIV disease in the United States. AIDS Carel 16 (2004) 219-230
21. Hinkin C.H., Hardy D.J., Mason K.I., Castellon S.A., Durvasula R.S., Lam M.N., and Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18 (2004) S19-S25
22. Kalichman S.C., and Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex. Transm. Dis. 79 (2003) 59-61
23. Lucas G.M., Gebo K.A., Chaisson R.E., and Moore R.D. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treament outcomes in an urban clinic. AIDS 16 (2002) 767-774
24. Martini M., Recchia E., Nasta P., Castanotto D., Chiaffarino F., Parazzini F., and Agnoletto V. Illicit drug use: can it predict adherence to antiretroviral therapy?. Eur. J. Epidemiol. 19 (2004) 585-587
25. Mayfield D., McLeod G., and Hall P. The CAGE questionnaire: validation of a new alcoholism instrument. Am. J. Psychiatry 131 (1974) 1121-1123
26. Mehta S., Moore R.D., and Graham N.M. Potential factors affecting adherence with HIV therapy. AIDS 11 (1997) 1665-1670
27. Moatti J.P., Carrieri M.P., Spire B., Gastaut J.A., Cassuto J.P., and Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS 14 (2000) 151-155
28. Moatti J.P., and Spire B. Living with HIV/AIDS and adherence to antiretroviral treatments. In: Moatti J.P., Souteyrand Y., Prieur A., Sandfort T., and Aggleton P. (Eds). AIDS in Europe: New Challenges for the Social Sciences (2000), Routledge, London 57-73
29. Mohammed H., Kieltyka L., Richardson-Alston G., Magnus M., Fawal H., Vermund S.H., Rice J., and Kissinger P. Adherence to HAART among HIV-infected persons in rural Louisiana. AIDS Patient Care STDS 18 (2004) 289-296
30. Moutouh L., Corbeil J., and Riehman D.D. Recombination leads to the rapid emergence of HIV-1 dially resistant mutants under selective drug pressure. Proc. Natl. Acad. Sci. USA 93 (1996) 6106-6111
31. Murphy D.A., Marelich W.D., Hoffman D., and Steers W.N. Predictors of antiretroviral adherence. AIDS Care 16 (2004) 471-484
32. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med. 338 (1998) 853-860
33. Palepu A., Horton N.J., Tibbetts N., Meli S., and Samet J.H. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems the impact of substance abuse treatment. Addiction 99 (2004) 361-368
34. Palepu A., Tyndall M.W., Li K., Yip B., O'Shaughnessy M.V., Schechter M.T., Montaner J.S., and Hogg R.S. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J. Urban Health 80 (2003) 667-675
35. Samet J.H., Horton N.S., Meli S., Freedberg K.A., and Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin. Exp. Res. 28 (2004) 572-577
36. Sherr L. Adherence - sticking to the evidence. AIDS Care 12 (2000) 373-375
37. Spire B., Duran S., Souville M., Leport C., Raffi F., and Moatti J.P. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc. Sci. Med. 54 (2002) 1481-1496
38. Tucker J.S., Burnam M.A., Sherbourne C.D., King F.Y., and Gifford A.L. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am. J. Med. 114 (2003) 573-580
39. Wagner G.J., and Ryan G.W. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDS 18 (2004) 385-393
40. Wainberg M.A., and Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA 279 (1998) 1977-1983
41. Ware N.C., Wyatt M.A., and Ingenberg T. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Soc. Sci. Med. 61 3 (2006) 565-576